子宫内膜不典型增生术后病理升级为子宫内膜癌的危险因素分析

目的:研究子宫内膜不典型增生(AEH)术后病理升级为子宫内膜癌(EC)的相关危险因素。方法:选择2017年7月至2019年9月就诊于安徽医科大学第一附属医院门诊,经过诊断性刮宫明确为AEH并行全子宫切除术的166例患者为研究对象,并根据术后病理检查结果分为EC组(94例)和非EC组(72例)。分析患者术前与术后病理诊断的符合率、漏诊率及单因素和多因素Logistic回归分析AEH术后病理升级为EC的高危因素。结果:诊断性刮宫对AEH诊断的符合率为36.14%(60/166),对EC诊断的漏诊率为56.63%(94/166)。单因素分析结果示,EC组患者的发病年龄均值及年龄≥49.5岁、术前CA₁₂₅均值及CA₁₂₅升高、合并糖尿病的比例均显著高于非EC组患者,差异有统计学意义(P<0.05)。多因素二分类Logistic回归分析示,发病年龄≥49.5岁(OR 4.548,95%CI 2.246～9.210,P=0.000)、CA₁₂₅升高(OR 7.635,95%CI 2.326～25.060,P=0.001)为A...     

子宫内膜异位症相关不孕合并内膜息肉的高危因素分析

目的 分析子宫内膜异位症（EM）相关不孕患者合并子宫内膜息肉（EP）的高危因素。方法 选取107例因不孕症接受宫腹腔镜联合手术,且经腹腔镜检查及术后病理证实为EM患者,根据宫腔镜检查及术后病理结果,将患者是否合并EP分为EP组（60例）与非EP组（47例）。研究两组临床资料,探索EM不孕患者合并EP的高危因素。结果 107例EM不孕患者中EP的发生率为56.1%。单因素分析显示：EP组年龄均值低于非EP组（P<0.05）,EP组年龄≤36.5岁比例、子宫内膜厚度均值、子宫内膜厚度≥10.0 mm比例及原发性不孕比例均高于非EP组,差异有统计学意义（P<0.05）,不同病理类型EM患者EP发生率比较,差异无统计学意义（P>0.05）。多因素二分类Logistic回归分析显示：发病年龄≤36.5岁（OR=5.409,95%CI 1.446,20.235,P<0.05）、子宫内膜厚度≥10.0 mm(OR=28.035,95%CI 7.152,109.891,P<0.01)是EM合并EP的独立危险因素,而原发性不孕（OR=1.033,95%CI 0.357,2....     

人附睾蛋白4在子宫内膜非典型增生患者中筛查子宫内膜癌的临床价值

目的：探讨人附睾蛋白4（human epididymis protein 4,HE4）检测在诊断性刮宫（诊刮）病理为子宫内膜非典型增生（atypical endometrial hyperplasia,AEH）患者中筛查子宫内膜癌（endometrial carcinoma,EC）的临床价值。方法：选取2011年1月—2014年12月在天津市中心妇产科医院诊刮病理为AEH进而行手术治疗的患者,术前采用电化学发光免疫分析法检测患者血清HE4、CA125和CA199水平,根据术后病理分为EC组和AEH组,分析2组患者肿瘤标记物的水平差异。制作受试者工作特征曲线（ROC）,以曲线下面积（AUC）反映肿瘤标记物的诊断价值。结果：入选的118例诊刮病理为AEH的患者中,31例术后被诊断为EC（EC组）,其血清HE4、CA125和CA199水平分别为73.4 pmol/L、31.4 kU/L和23.3 kU/L;87例术后诊断仍为AEH（AEH组）,上述3种肿瘤标记物的水平分别为44.3 pmol/L、17.0 kU/L和19.0 kU/L;EC组HE4和CA125水平高于AEH组,差异有统计学意义（P＜0.05）,而CA199水平差异无统计学意义（P＞0.05）。EC组以AEH组为参照时,HE4和CA125单独检测的AUC分别为0.785和0.706,两者联合检测的AUC为0.867,敏感度为76.6%。结论：EC患者血清HE4和CA125水平明显高于AEH患者,两者联合检测有助于筛查出诊刮病理为AEH人群中漏诊的EC患者。     

子宫内膜增生并发子宫内膜癌的高危因素及预后分析

目的:研究子宫内膜增生患者并发子宫内膜癌的高危因素及其预后的分析。方法:回顾性分析2014年1月至2015年1月行全子宫切除术,且术前诊断性刮宫(诊刮)提示子宫内膜增生的74例患者的临床资料。根据全子宫切除术后的病理结果分为子宫内膜癌组(28例)和子宫内膜增生组(46例),对两组的临床特征进行比较,并分析发生子宫内膜癌的高危因素。结果:①74例患者中37.8%(28/74)并发子宫内膜癌。单因素和多因素分析结果均提示:年龄≥48岁和诊刮病理为重度子宫内膜不典型增生(重度AEH)为发生子宫内膜癌的高危因素(P0.05)。②不伴任何高危因素、伴有1个高危因素和2个高危因素的患者并发子宫内膜癌的几率分别为5.0%(1/20)、46.2%(12/26)和81.8%(9/11),差异有统计学意义(P0.05),且随着高危因素数目的增加发生子宫内膜癌的风险显著升高(OR 16.3,95%CI 1.9~140.3,P=0.011;OR 85.5,95%CI 6.8~1071.3,P=0.001)。③28例并发子宫内膜癌患者均为早期子宫内膜样癌,25例为高分化,3例为中分化。平均随诊13.3±6.3月,没有患者复发或死亡。结论:子宫内膜增生患者并发子宫内膜癌的发生率较高,特别是对于高龄(≥48岁)、诊刮病理为重度AEH的患者并发风险显著增加,但并发的子宫内膜癌多为分化较好的早期子宫内膜样癌,近期预后良好。     

绝经后出血的高危因素及预测子宫内膜病变模型的建立

目的:分析绝经后出血(PMB)患者的病因及子宫内膜病变特点,利用子宫内膜病变的高危因素建立预测子宫内膜良性病变(EBL)和子宫内膜癌(EC)的模型。方法:选择2016年1月至2019年12月在西安交通大学第一附属医院就诊的PMB患者328例为研究对象,分析PMB病因,对其中可疑子宫内膜病变行内膜病理检查的208例患者根据其病理检查结果分为正常子宫内膜组(NE组,35例)、EBL组(134例)和EC组(39例),比较不同的绝经年限(1～3年、3～5年、5～10年、≥10年)患者中EBL[子宫内膜息肉(EP)、子宫内膜增生不伴非典型增生(EH)、子宫内膜非典型增生(AEH)]和EC的发生率,并对NE组、EBL组和EC组患者子宫内膜超声影像学特点和高危因素进行分析,使用受试者工作特征曲线(ROC)根据子宫内膜病变高危因素建立预测模型。结果:(1)328例PMB患者中老年性阴道炎所占比例最高(32.32%),其次EBL中的EH患者占17.68%,而EC患者占11.89%。(2)不同绝经年限组中EP、EC发生率比较,差异有统计学意义((印)P(正)<0.05),而EH、AEH发生率比较差异无统计学意义((印)P(正)>0.05),绝经1～3年组EP和EH的发生率最高(分别为25.68%、20.27%),绝经≥10年组AEH和EC的发生率最高(分别为19.57%、28.26%)。(3)超声影像学检查中NE组、EBL组及EC组的子宫内膜厚度均值及子宫内膜回声不均匀、内膜与肌层分界线不清晰、内膜血流分级(Ⅱ级、Ⅲ级)的比例随着病变严重程度均呈递增趋势((印)P(正)<0.05)。(4)3组患者在子宫内膜病变高危因素：不同的年龄、子宫内膜厚度、绝经年龄,及是否反复阴道流血、肥胖、糖尿病、服用他莫昔芬的比较,差异均有统计学意义((印)P(正)<0.05)。(5)高危因素预测模型对EBL(灵敏度85.3%,特异度67.8%,AUC=0.791)和EC(灵敏度89.7%,特异度72.3%,AUC=0.854)均有较好的预测价值。结论:PMB患者病因中以老年性阴道炎和EBL为主,但EC不容忽视,特别是伴有子宫内膜病变高危因素者。PMB患者不同子宫内膜病理类型超声影像学特点有差异,绝经≥10年组AEH和EC发生率最高,采用子宫内膜病变高危因素建立的模型对EBL和EC具有较好的预测价值,值得临床关注。     

绝经后子宫内膜息肉合并子宫内膜不典型增生及子宫内膜癌高危因素分析

目的分析绝经后妇女子宫内膜息肉(endometrial polyps,EMPs)发生恶变的相关危险因素。方法回顾性分析2001年4月至2009年12月北京大学人民医院妇产科收治的489例经宫腔镜病理确诊为EMPs的患者,依据病理类型分为良性组(471例)和非典型增生/恶性组(18例),比较两组患者的临床特征和子宫内膜息肉恶变的相关危险因素。结果绝经后子宫内膜息肉患者中,子宫内膜息肉合并不典型增生者11例(2.20%,11/489),子宫内膜息肉合并子宫内膜癌者7例(1.43%,7/489)。单因素分析的各临床因素中,绝经≥10年(OR=15.60,95%CI:2.05～118.57)和绝经后出血(OR=4.08,95%CI:1.31～12.70)是与子宫内膜癌前病变或子宫内膜癌相关的危险因素(P<0.05),而高血压、糖尿病、肥胖和子宫内膜息肉病史等因素比较,差异无统计学意义(P>0.05)。结论绝经后子宫内膜息肉发生癌前病变和子宫内膜癌风险增加,绝经≥10年和有绝经后出血症状是发生癌前病变和癌的危险因素。     

子宫内膜非典型增生术后病理升级的高危因素分析

目的 探讨子宫内膜不典型增生术后病理升级的高危因素并构建预测模型,旨在为早期识别高危人群及制定针对性管理方案提供更多借鉴。方法 回顾性纳入2019年1月至2022年1月在中国人民解放军海军第九七一医院行诊断性刮宫确诊子宫内膜不典型增生的患者共110例,根据全子宫切除术后是否升级为恶性病变分为恶变组（37例）和非恶变组（73例）,采用单因素和多因素法评估刮宫术后病理组织学检查升级为恶性病变的独立危险因素,构建基于上述独立危险因素列线图模型,描绘受试者工作特征（ROC）曲线分析列线图模型用于刮宫术后病理组织学检查升级为恶性病变风险的预测临床效能。结果 单因素分析结果显示,绝经状态和超声评估>Ⅰ级血流信号均可能与刮宫术后病理组织学检查升级为恶性病变有关（P <0.05）;Logistic回归模型多因素分析结果显示,已绝经和超声评估>Ⅰ级血流信号均是刮宫术后病理组织学检查升级为恶性病变的独立危险因素（P <0.05）。基于上述独立危险因素构建列线图,其中已绝经和超声评估>Ⅰ级血流信号分别赋值为23分、100分;Bootstrap软件内部验证结果显示上述列线图模型一...     

不同分子特征对子宫内膜癌和子宫内膜非典型增生患者保留生育功能治疗结局的影响

目的探讨分子分型及关键致癌基因突变对子宫内膜癌(EC)和子宫内膜非典型增生(AEH)患者保留生育功能治疗结局的影响。方法收集2021年1月至2023年3月在复旦大学附属妇产科医院接受高效孕激素保留生育功能治疗并进行分子分型及关键致癌基因检测的171例EC和AEH患者进行回顾性分析;所有患者在开始孕激素治疗前及治疗后约每3个月进行1次宫腔镜病灶切除及子宫内膜活检病理检查, 用于评估疗效;进一步对影响EC和AEH患者治疗结局的相关因素进行分析。结果 171例EC和AEH患者的中位年龄为32岁;EC 86例, AEH 85例;分子分型:无特殊分子改变(NSMP)型157例(91.8%), 错配修复缺陷(MMR-d)型9例(5.3%), POLE突变型3例(1.8%), p53异常型2例(1.2%)。NSMP型与MMR-d型患者治疗40周累积完全缓解(CR)率比较, 差异无统计学意义(分别为61.6%、60.0%;P=0.593);但与NSMP型患者相比, MMR-d型患者CR后的1年累积复发率显著升高(分别为14.4%、50.0%;P=0.015)。多因素分析显示, 子宫内膜病变组织中存在P...     

腹腔镜子宫腺肌病灶切除术术后复发危险因素分析

目的：探讨腹腔镜子宫腺肌病灶切除术术后复发情况及其相关临床危险因素。方法：分析2010年1月—2015年1月在首都医科大学附属北京妇产医院妇科微创中心行腹腔镜子宫腺肌病灶切除术的109例患者临床资料，随访术后复发情况，分析患者术后复发的相关临床因素。结果：术后12、24、36个月的累积复发率分别为14.9%、22.7%及25.7%。年龄对术后复发率有显著影响，年龄每增加1岁，复发风险就降低10%（RR=0.900，95%CI：0.822～0.986，P=0.023）；术前子宫体积增大是术后复发高危因素（RR=1.289，95%CI：1.121～1.678，P=0.005）；术后促性腺激素释放激素激动剂（GnRHa）治疗是术后复发保护性因素（RR=0.407，95%CI：0.185～0.895，P=0.025）。患者的孕次、术前痛经评分、最大腺肌瘤直径、腺肌瘤位置、术前药物治疗、手术方式、合并子宫内膜异位症等均不是增加术后复发率的危险因素。结论：患者年龄小、术前子宫体积增大、术后未应用GnRHa治疗是腹腔镜子宫腺肌病灶切除术术后复发率增加的危险因素。     

甲地孕酮联合二甲双胍治疗早期子宫内膜样腺癌和子宫内膜非典型增生的前瞻性研究

目的 评价醋酸甲地孕酮（MA）联合盐酸二甲双胍缓释片（MET）用于子宫内膜非典型增生和早期子宫内膜样腺癌保留生育功能治疗的效果、复发及治疗后妊娠情况。方法 纳入58例早期（ⅠA期G1级）子宫内膜样腺癌（endometrial carcinoma, EC）和子宫内膜非典型增生（atypical endometrial hyperplasia, AEH）患者。采用数字表法随机分为研究组30例患者,给予MA 160 mg/d+MET 1700 mg/d;对照组28例患者,给予MA 160 mg/d,分别连续用药3个月为1个疗程,每3个月进行宫腔镜检查及诊刮评估子宫内膜改善情况。结果 研究组30例患者中,20例AEH,10例早期EC;治疗6个月时,21例（70.0%, 12/30）病理完全反应（complete response, CR）。对照组28例患者中,18例AEH,10例早期EC,17例（60.7%, 17/28）达到CR,两组CR比较,差异无统计学意义（P>0.05）。治疗9个月时,研究组CR(76.7%, 23/30)和对照组CR(71.4%,20/28)比较,差异无统计学意...     

Coexisting endometrial cancer in patients with a preoperative diagnosis of atypical endometrial hyperplasia

AIM: To investigate the possibility of coexisting endometrial cancer (EC) in patients with atypical endometrial hyperplasia (AEH). METHODS: Forty-six consecutive women who underwent hysterectomy for AEH were analyzed. RESULTS: Final histopathological evaluation of hysterectomy specimens revealed EC in 11 patients (23.9%). Preoperative diagnosis of AEH was established by pipelle biopsy in eight patients and curettage was performed in the remaining patients. Of the patients with pipelle biopsy, two had a diagnosis of EC (25%), whereas nine women who underwent curettage, were further diagnosed as having EC (23.7%) (P > 0.05). Four (13.3%) of 30 women who had frozen sections at hysterectomy, were diagnosed with EC. Diagnosis of EC was missed in two patients (50%) at frozen section. In contrast, seven of 16 women (43.7%) who did not have frozen section, had EC. CONCLUSION: A relatively high incidence of EC is seen in patients with a diagnosis of AEH. Diagnostic results of pipelle biopsy and curettage were comparable. Frozen sections of hysterectomy specimens does not guarantee to exclude the possibility of EC, especially in patients with no myometrial invasion.     

长链非编码RNA高表达与子宫内膜癌病理特征和预后关系的Meta分析

目的：分析长链非编码RNA（lncRNA）高表达与子宫内膜癌病理特征及预后的相关性,系统评价其对子宫内膜癌患者预后的预测价值。方法：计算机检索Pubmed、Embase、Web of Science、中国知网、万方和维普等数据库相关文献,检索时间为建库至2017年10月9日,根据制定的纳入和排除标准选择文献并进行质量评价,提取子宫内膜癌患者的病理特征和生存相关数据。应用Revman 5.3及Stata 12.0统计软件对数据进行合并分析。结果：共纳入9篇文献（其中1篇中文、8篇英文）,包含775例子宫内膜癌患者。Meta分析结果显示,lncRNAs高表达与国际妇产科联盟（FIGO）分期（OR=2.41,95%CI：1.11～5.25,P=0.03）、组织学分级（OR=2.01,95%CI：1.19～3.41,P=0.009）、肌层浸润（OR=2.29,95%CI：1.16～4.51,P=0.02）及淋巴结转移（OR=4.00,95%CI：2.40～6.66,P＜0.000 01）均显著相关;与孕激素受体（PR）及雌激素受体（ER）阳性表达均无关（P＞0.05）;与lncRNAs低表达组比较,高表达组患者OS较短（HR=2.43, 95%CI：1.55～3.80）;亚组分析HOTAIR高表达与OS相关（HR=3.73,95%CI：1.21～11.49）。结论：lncRNAs高表达对子宫内膜癌患者的预后具有重要预测价值。lncRNAs表达越高、临床分期及组织学分级越高、肌层浸润越深,淋巴结转移风险亦增加,总生存期缩短,预后越差。     

Frozen section pathology at time of hysterectomy accurately predicts endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia

Objectives

A significant number of women diagnosed with atypical endometrial hyperplasia (AEH) on endometrial biopsy will be diagnosed with endometrial cancer (EC) on the hysterectomy specimen at permanent section. Surgical treatment for AEH and EC differ substantially. We have assessed the concordance in EC between frozen and permanent sections on patients undergoing hysterectomy for AEH.

Materials and methods

A retrospective review of 66 frozen sections on patients undergoing hysterectomy for AEH was performed. Frozen and permanent section diagnoses were categorized as negative or positive for malignancy. Permanent section carcinomas were classified as low or high risk based on their histopathology, myometrial invasion and differentiation. Correlation between frozen and permanent section and sensitivity, specificity, PPV, NPV and accuracy of frozen section in predicting EC in permanent section were calculated. Likelihood of diagnosing EC on frozen section was compared based on risk stratification at permanent section.

Results

Frozen and permanent sections revealed malignancy in 43.9% and 56% of the patients respectively. 94.1% of high risk carcinomas were identified as EC at frozen section as compared to 55% of low risk EC. Concordance was good (κ = 0.75). Sensitivity, specificity, NPV, PPV and accuracy in predicting EC at frozen section were 73%, 93.1%, 73% and 93.1% respectively. Carcinomas were detected at frozen section significantly more often if they were at high risk.

Conclusions

The substantial agreement between frozen and permanent sections allows minimizing under- and overtreatment of women undergoing hysterectomy for AEH. High risk EC are efficiently identified in frozen section.     

Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia

OBJECTIVE: Atypical endometrial hyperplasia (AEH) has been associated with the presence of concomitant endometrial carcinoma (EC). The aim of this study is to examine the frequency of coexisting endometrial carcinoma when atypical endometrium hyperplasia was found upon biopsy. We also evaluated the influence of preoperative diagnostic techniques (pipelle and dilation and curettage (D&C)), and the value of transvaginal ultrasound in detecting unexpected tumor invasion. STUDY DESIGN: Between January 1992 and December 2003, at the Department of Obstetrics and Gynecology, University of Parma, and Policlinico S. Matteo, Pavia, 70 consecutive patients subjected to total hysterectomy with a histological diagnosis of AEH were retrospectively selected. 52/70 patients underwent vaginal hysterectomy, with bilateral salpingo-oophorectomy (BSO) whereas 18/70 had abdominal hysterectomy with BSO within 8 weeks since the diagnosis of AEH. RESULTS: We found in 30 of the 70 patients with atypical endometrial hyperplasia in the biopsy coexisting endometrial carcinoma (43%). No differences in diagnostic accuracy between the pipelle method and D&C were found. CONCLUSION: Transvaginal ultrasound was not a feasible method for predicting EC. After a follow-up of an average of 5 years there was, neither in the abdominal operated patients nor in the vaginal operated patients, a recurrence of disease.     

高龄、肥胖、早孕期体重增长、一级亲属糖尿病家族史单因素以及复合因素对妊娠期糖尿病发病的影响

目的:研究高龄、孕前体质量指数(Pre-BMI)、孕期体重增长、一级亲属即父母患糖尿病单因素以及复合因素对妊娠期糖尿病(GDM)发病的影响,以达到控制某个可控因素来降低GDM发病风险。方法:对上海交通大学附属第一人民医院南院731例孕妇的年龄、孕前BMI、早孕期增重、糖尿病家族史进行logistic单因素回归分析并进行复合因素分析。结果:妊娠年龄(OR=1.071,95%CI=1.034~1.110,P=0.000),孕前BMI(OR=1.535,95%CI=1.087~2.170,P=0.015),早孕期体重增长(OR=1.132,95%CI=1.041~1.231,P=0.004),家族糖尿病史(OR=2.386,95%CI=1.393~4.086,P=0.002)。妊娠期合并1个高危因素孕妇患GDM的危险度是合并0个高危因素的1.966倍(95%CI=1.277~3.027,P=0.002),合并2个高危因素孕妇患GDM的危险度是合并0个高危因素的3.060倍(95%CI=1.912~4.898,P=0.000),合并≥3个高危因素孕妇患GDM的危险度是合并0个高危因素的8.444倍(95%CI=4.077~17.488,P=0.000)。结论:妊娠期间合并高危因素数越多,GDM发生危险度越高。对于合并高危因素的妇女,产科医师可在其备孕咨询时或初次产检时给予指导,降低可改变的1个或2个因素,达到很大程度降低GDM发病风险。     

Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia

Objective

To evaluate the prevalence of concurrent endometrial carcinoma in women diagnosed with atypical endometrial hyperplasia (AEH) by endometrial biopsy.

Study design

We retrospectively analyzed the medical records of 126 patients who underwent hysterectomies for AEH diagnosed by endometrial biopsy from 1999 to 2008. AEH was initially diagnosed by dilatation and curettage (98 cases) or endometrial biopsy with a Z-sampler (24 cases). The remaining four cases were diagnosed by hysteroscopic polypectomy. The results of the endometrial biopsies were graded on an ordinal scale and were compared with pathologic features obtained at the hysterectomy.

Results

In patients preoperatively diagnosed with AEH by biopsy, hysterectomy specimens revealed a rate of simple or complex endometrial hyperplasia without atypia of 27% with AEH and normal proliferative phases found in 54.7 and 7.9% of specimens, respectively. The incidence of endometrial carcinoma was considerably high (13/126, 10.3%). Eleven of 13 cases were confined to the endometrium and the remaining two were located at the adenomyosis without myometrial invasion. All patients with endometrial carcinoma displayed coexisting atypical complex hyperplasia following hysterectomy.

Conclusions

Biopsy specimens showing AEH, particularly atypical complex hyperplasia, are associated with a risk of coexisting endometrial carcinoma. When considering management strategies for women with a biopsy diagnosis of AEH, clinicians should take into account the considerable rate of concurrent endometrial cancer and the discrepancy with pathologic diagnosis. Treatment modalities may differ depending on population as the rates of concurrent endometrial cancer with AEH and myometrial invasion vary by geographical location.     

Management of abnormal uterine hemorrhage with atypical endometrial hyperplasia by transcervical resection of endometrium

The aim of the study was to assess the feasibility and effect of treating atypical endometrial hyperplasia (AEH) with transcervical resection of endometrium (TCRE). Five cases of AEH incapable of hysterectomy for various reasons were treated with TCRE. All patients were followed up for 3-4 years postoperation to evaluate the thickness of endometrium, uterine cavity, and prognosis of the disease. All the patients provided informed consent for TCRE. In all five cases treated with TCRE, case 1 was for senility, hypertension, diabetes mellitus, and obesity; case 4 for senility, obsolete cerebral infarction, and hemiplegia; case 5 for uremia and chronic dysfunction of coagulation after renal transplantation; cases 2 and 3 for rejection of hysterectomy. All cases were followed up for more than 3 years after operation. Four had amenorrhea and one had dropping menses. The thickness of endometrium was no more than 5 mm in all the cases. TCRE is one available microinvasive surgery alternative to hysterectomy for AEH patients contraindicated to hysterectomy.     

早期宫颈癌锥切标本宫旁浸润的影响因素分析

目的：探讨早期宫颈癌锥切标本宫旁浸润（PI）的影响因素。方法：回顾性分析大连市妇幼保健院2008年1月—2018年2月经宫颈锥切确诊为宫颈癌后行根治性子宫切除术（RH）+腹膜后淋巴结切除术的200例Ⅰa2～Ⅰb1期宫颈癌患者，分析早期宫颈癌PI的影响因素。结果：200例患者中有15例（7.5%）PI阳性，185例（92.5%）PI阴性。单因素分析显示，PI与年龄、病理类型、国际妇产科联盟（FIGO）分期、病理组织学分级、肿瘤大小和切缘状态无关（均P＞0.05），与淋巴脉管间隙浸润（LVSI）和淋巴结转移有关（均P＜0.05）。多因素分析显示，LVSI阳性（OR=5.456，95%CI：1.669～17.833，P=0.005）和淋巴结转移阳性（OR=6.725，95%CI：1.833～24.669，P=0.004）是PI的独立危险因素。结论：早期宫颈锥切标本中LVSI、淋巴结转移与PI有关，可作为PI的预测因子。